You are here

Mushroom Extract May Eradicate Human Papilloma Virus in Women

Daily Use of AHCC Supplement Could Support Immune System, Eliminate HPV

A presentation at the October conference of the Society for Integrative Oncology in Scottsdale, Arizona, revealed that daily use of the AHCC supplement could support the host immune system to eradicate HPV infection in women.

Results from an ongoing clinical trial evaluating AHCC for the treatment of HPV indicated that close to 60 percent of the patients showed no signs of the infection at six months of treatment. The randomized, double-blind, placebo-controlled study is following 50 women for up to 12 months, with one group taking six 500-mg capsules of AHCC and a second group receiving placebo.

Currently, there is no standard of care for persistent, high-risk HPV infections. AHCC is a natural, immune-modulating compound derived from specially cultured medicinal mushroom roots. The supplement is well-tolerated in patients who receive it and studies indicate that it works by increasing the number and/or activity of natural killer (NK) cells, killer T-cells, dendritic cells, and cytokines. This enables the body to effectively fight infections.

Multiple studies have demonstrated that AHCC improves the quality of life of cancer patients. In addition, the supplement has been shown to reduce viral loads in patients with hepatitis C as well as helping patients with non-viral liver disease.

Source: BioSpace.com, November 5, 2018

Recent Headlines

Scenesse is new treatment for people with rare, painful light sensitivity disease
Humira, Rituxan top list of drugs that added $5.1 billion to nation's health care bill
Lower court rulings cleared the way for generic versions of the MS drug
Maryland man wins lawsuit that alleges that the company's antipsychotic caused his gynecomastia
Antidepressants, ADHD meds are also used to self-poison
Descovy joins Truvada, another Gilead product, in the HIV prophylaxis market
Data show PTC Therapeutics drug preserves lung function
U.S. maintains measles elimination status as NY outbreak ebbs
Study lists steps that could save close to $300 billion a year